Liu Y et al. found that overexpression of DUSP4 may promote the EMT in breast cancer, whereas knockdown of DUSP4 enhanced the sensitivity of chemotherapeutic agents in breast cancer cells [28]. The gene discussed is DUSP4; the disease is breast carcinoma.